Fundz
A company that just raised surges hiring in 30 to 60 days. Fundz shows you the money, about a month before the job ad.See it live →

Slate Medicines Appoints Kenneth Koblan As Chief Scientific Officer

RECENTLY ACQUIREDSep 14, 2026•about 3 hours ago

Position

Chief Scientific Officer

Company

Slate Medicines

Kenneth Koblan
RaleighBiotechnologyHealth Care

Description

Slate Medicines Inc. has announced the appointment of Kenneth Koblan, PhD, as Chief Scientific Officer. Dr

Company Information

Company

Slate Medicines

Location

Raleigh, North Carolina, United States

About

Slate Medicines, Inc. is a biotech company focused on advancing next generation therapeutics for migraine and other headache disorders. The Company’s lead program, SLTE-1009, is a potential best-in-class subcutaneous anti-PACAP for the prevention of migraine and other headache disorders. It aims to provide new options for patients underserved by current treatments. Slate Medicines is backed by leading healthcare investors, including RA Capital Management, Forbion, and Foresite Capital.

Don't miss Slate Medicines's next move

Get an email the moment Slate Medicines changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Slate Medicines's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Slate Medicines changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.